350 related articles for article (PubMed ID: 8322428)
1. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
[No Abstract] [Full Text] [Related]
2. IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.
Mehrani T; Petri M
J Rheumatol; 2011 Mar; 38(3):450-3. PubMed ID: 21123325
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
Mak A; Cheung BM; Mok CC; Leung R; Lau CS
Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
[TBL] [Abstract][Full Text] [Related]
4. Vascular complications in lupus nephritis and lupus-like syndromes.
Seshan SV
Wien Klin Wochenschr; 2000 Aug; 112(15-16):687-91. PubMed ID: 11020958
[No Abstract] [Full Text] [Related]
5. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
6. [Unusual 15-year course of systemic lupus erythematosus with glomerulonephritis].
Mrowka C; Thoenes GH; Hübner K; Thoenes W
Internist (Berl); 1992 Nov; 33(11):763-7. PubMed ID: 1478833
[No Abstract] [Full Text] [Related]
7. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
8. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
9. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
[TBL] [Abstract][Full Text] [Related]
10. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
11. Significance of antinuclear antibody (ANA) immunofluorescent patterns and titers in systemic lupus erythematosus nephritis.
Akbar S; Tello AI; Luvira U; Heinzerling R; Romanski R; Levin NW; Burnham TK
Henry Ford Hosp Med J; 1988; 36(2):121-9. PubMed ID: 3068209
[No Abstract] [Full Text] [Related]
12. Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy.
Eilertsen GØ; Fismen S; Hanssen TA; Nossent JC
Nephrol Dial Transplant; 2011 Feb; 26(2):620-7. PubMed ID: 20647194
[TBL] [Abstract][Full Text] [Related]
13. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
14. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
Mackay IR
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
[No Abstract] [Full Text] [Related]
15. Immuno-histological changes in lupus nephritis in female patients: a four-year study.
Qayyum A; Nagy AA
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):658-63. PubMed ID: 18580033
[TBL] [Abstract][Full Text] [Related]
16. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
Suzuki N; Harada T; Mizushima Y; Sakane T
J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
[TBL] [Abstract][Full Text] [Related]
17. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
[TBL] [Abstract][Full Text] [Related]
18. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
Kozlovskaia NL; Kabaenkova GS; Varshavskiĭ VA; Shvetsov MIu
Klin Med (Mosk); 1995; 73(3):93-6. PubMed ID: 8577127
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibody negative lupus associated with dystrophic calcification.
Morris CN; Calobrisi SD; Matteson EL
J Rheumatol; 1998 Apr; 25(4):825-6. PubMed ID: 9558201
[No Abstract] [Full Text] [Related]
20. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
